Community Research and Development Information Service - CORDIS

Results 1 - 10 of 384
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
The NGF system and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain
ID: 603191
Start date: 2014-04-01, End date: 2017-12-31
So far, there are no effective treatments for neuropathic pain (NP), and current treatments suffer from serious unwanted side effects. The NGF ligand-receptor system has recently emerged as a novel target for NP of great therapeutic potential, a master regulator, controlling ...
Programme: FP7-HEALTH
Record Number: 185456
Last updated on: 2017-10-06
King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies
ID: 306029
Start date: 2013-04-01, End date: 2017-03-31
Extensive clinical and epidemiological data clearly shows that chronic periodontal disease (PD), the most prevalent infectious inflammatory disease of mankind, is strongly linked to systemic inflammatory diseases such as cardiovascular diseases (CVD) , rheumatoid arthritis (R...
Programme: FP7-HEALTH
Record Number: 106057
Last updated on: 2017-10-06
Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE
ID: 305937
Start date: 2012-09-01, End date: 2018-08-31
The BERENICE consortium is aiming at providing a new and cost-effective solution to a better treatment for Chagas chronic patients. Please see its objectives below : Main objective • Obtain a more effective, better tolerated and cheaper formulation of a drug with trypanocidal...
Programme: FP7-HEALTH
Record Number: 106038
Last updated on: 2017-10-06
Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing
ID: 602407
Start date: 2013-09-01, End date: 2018-02-28
Conduct Disorder (CD) and Oppositional Defiant Disorder with symptoms of Conduct Disorder (which is included among the abbreviation “CD” throughout the proposal) has a highly negative impact for the affected individual as well as for families and society. Although the number ...
Programme: FP7-HEALTH
Record Number: 110199
Last updated on: 2017-09-24
Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and non-drug Therapy in Older peRsons
ID: 305930
Start date: 2012-10-01, End date: 2018-06-30
The European population of older people with multiple chronic diseases (multimorbidity) is increasing steadily in tandem with the rising population of people aged ≥ 65 years. Older multimorbid people are at high risk of polypharmacy (PP), inappropriate prescribing (IP), adver...
Programme: FP7-HEALTH
Record Number: 105397
Last updated on: 2017-09-24
Novel antifungals to treat resistant organisms
ID: 601963
Start date: 2013-07-01, End date: 2016-06-30
Invasive fungal diseases are estimated to kill 1.5 million people each year. The incidence of mortality has risen significantly across the EU over the last 20 years due to an expansion of at risk patient populations. Given the obvious importance of these diseases it is perhap...
Programme: FP7-HEALTH
Record Number: 108714
Last updated on: 2017-09-10
Platform for sharing best practices for management of rare diseases
ID: 305690
Start date: 2013-01-01, End date: 2016-12-31
RARE-Bestpractices will develop a sustainable networking platform, supporting the collection of standardized and validated data and efficient exchange of knowledge and reliable information on rare diseases (RD). RD are characterized by low prevalence (EU – 5:10000 persons). T...
Programme: FP7-HEALTH
Record Number: 105806
Last updated on: 2017-09-10
Generation of  a new class of antiretrovirals targeting HIV-cellular cofactors interactions
ID: 305137
Start date: 2012-10-01, End date: 2015-09-30
Highly active antiretroviral therapy is effective at controlling HIV-1 replication, however emergence and transmission of drug-resistant viruses is increasing, including viruses resistant to the newly developped integrase catalytic inhibitors. It is essential that new antiret...
Programme: FP7-HEALTH
Record Number: 105307
Last updated on: 2017-09-10
Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression
ID: 279228
Start date: 2012-01-01, End date: 2015-12-31
Type 2 diabetes (T2DM) is preventable by sustained changes in diet and physical exercise. Despite this, modern societies are already approaching 10% population prevalence of diabetes, and another 15% with pre-diabetes. The costs of T2DM are huge, approaching 10% of all health...
Programme: FP7-HEALTH
Record Number: 101811
Last updated on: 2017-09-10
A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-09-10
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-10-18
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top